{"a":[{"_":"‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth","$":{"href":"/biotech/its-been-rollercoaster-novo-nordisks-cfo-reflects-pressure-drive-growth","hreflang":"en"}}]}

Summary

Novo Nordisk CFO Karsten Munk Knudsen discussed the company's second-quarter earnings results, characterizing the company's financial journey as a 'roller coaster' and expressing optimism about the CagriSema program despite navigating shifting business fortunes.